BIO-RAD LABORATORIES, INC. Allowance for Loan and Lease Losses, Write-offs
BIO-RAD LABORATORIES, INC. (BIO.B) reported Allowance for Loan and Lease Losses, Write-offs of $4.90 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-10-31.
Financial Statements › Notes › Credit Losses
us-gaap:AllowanceForLoanAndLeaseLossesWriteOffs · last filed 2024-10-31
- BIO-RAD LABORATORIES, INC. allowance for loan and lease losses, write-offs for the quarter ending 2024-09-30 was $2.00M, a 122.22% increase year-over-year.
- BIO-RAD LABORATORIES, INC. allowance for loan and lease losses, write-offs for the quarter ending 2024-06-30 was $1.70M.
- BIO-RAD LABORATORIES, INC. allowance for loan and lease losses, write-offs for the quarter ending 2024-03-31 was $1.20M, a 200.00% increase year-over-year.
- BIO-RAD LABORATORIES, INC. allowance for loan and lease losses, write-offs for the quarter ending 2023-09-30 was $900.00K, a 0.00% change year-over-year.
| Period end | Allowance for Loan and Lease Losses, Write-offs 3 month | Allowance for Loan and Lease Losses, Write-offs 6 month | Allowance for Loan and Lease Losses, Write-offs 9 month |
|---|---|---|---|
| 2024-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $3.70M derived: sum of 2 quarters · filed 2024-10-31 | $4.90M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $2.90M 10-Q · filed 2024-08-02 | |
| 2024-03-31 | $1.20M 10-Q · filed 2024-05-08 | ||
| 2023-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $900.00K derived: sum of 2 quarters · filed 2024-10-31 | $1.30M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $400.00K 10-Q · filed 2024-08-02 | |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-08 | ||
| 2022-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $1.80M derived: sum of 2 quarters · filed 2023-10-27 | $2.30M 10-Q · filed 2023-10-27 |
| 2022-06-30 | $900.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.40M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $500.00K 10-Q · filed 2023-05-05 | ||
| 2021-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-28 | $5.00M derived: sum of 2 quarters · filed 2022-10-28 | $5.60M 10-Q · filed 2022-10-28 |
| 2021-06-30 | $2.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-29 | $3.10M 10-Q · filed 2022-07-29 | |
| 2021-03-31 | $600.00K 10-Q · filed 2022-04-29 | ||
| 2020-09-30 | $900.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $1.60M derived: sum of 2 quarters · filed 2021-10-29 | $2.10M 10-Q · filed 2021-10-29 |
| 2020-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $1.20M 10-Q · filed 2021-07-30 | |
| 2020-03-31 | $500.00K 10-Q · filed 2021-04-30 |